Embecta

Embecta Cash Flow per Share

The Operating Cash Flow per Share of Embecta (EMBC) as of Nov 21, 2026 is 3.25 USD. In the previous year, Operating Cash Flow per Share was 0.61 USD — a change of 434.30% (higher).

Cash Flow per Share

3.25USD

YoY

434.30%

Last updated:

Operating Cash Flow per Share of Embecta is 2025 3.25 USD. Operating Cash Flow per Share of Embecta was 2024 0.61 USD. It decreases by 434.30% higher compared to the previous year.

The Embecta Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2019
8.63 USD
Jan 1, 2020
8.75 USD
Jan 1, 2021
8.00 USD
Jan 1, 2022
7.20 USD
Jan 1, 2023
1.17 USD
Jan 1, 2024
0.61 USD
Jan 1, 2025
3.25 USD
The Embecta Cash Flow per Share history
YEARCash Flow per ShareYoY
3.25USD+434.30%
0.61USD-48.16%
1.17USD-83.70%
7.20USD-9.94%
8.00USD-8.53%
8.75USD+1.33%
8.63USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Embecta Stock analysis

What does Embecta do? Embecta Corp. generates revenue through the manufacturing and distribution of medical devices for diabetes treatment, including pen needles, syringes, and safety injection devices. Its product portfolio features sterile, single-use pen needles designed for use with insulin pens, safety pen needles with dual-end shields to prevent needlestick injuries, and sterile insulin syringes for drawing insulin from vials. The company sells these products through retail, hospital, pharmacy, and institutional channels to customers managing diabetes. The firm’s digital application, integrated with its physical products, supports diabetes management by assisting users in tracking and administering insulin. This complementary digital solution enhances the value of its device offerings, attracting both individual consumers and healthcare institutions seeking comprehensive diabetes care solutions. Embecta Corp. focuses on providing end-to-end solutions for people living with diabetes, leveraging its product range and digital tools to address key challenges in diabetes management. Embecta is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Embecta stock

Operating Cash Flow per Share of Embecta is 3.25 USD in 2025.

Operating Cash Flow per Share of Embecta changed from 0.61 USD to 3.25 USD, representing a 434.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Embecta since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Embecta

All Key Metrics — Embecta